Dr. Wada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 N Medical Dr E13
Salt Lake City, UT 84132Phone+1 801-581-2955Fax+1 801-587-6346
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 2009 - 2012- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Dermatopathology, 2007 - 2008
University of Utah HealthResidency, Pathology-Anatomic and Clinical, 2003 - 2007
Saint Joseph HospitalResidency, Internal Medicine, 2002 - 2005
University of Hawaii, John A. Burns School of MedicineClass of 2002
Certifications & Licensure
AZ State Medical License 2019 - 2026
HI State Medical License 2020 - 2026
UT State Medical License 2004 - 2026
ID State Medical License 2015 - 2024
MN State Medical License 2007 - 2012
CO State Medical License 2002 - 2005- American Board of Dermatology Dermatology
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Dermatopathology
Clinical Trials
- ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome Start of enrollment: 2016 Oct 01
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsCutaneous mantle cell lymphoma histomorphologically mimicking subcutaneous panniculitis-like T-cell lymphoma: Case report.Caroline W. Laggis, Rodney R. Miles, Deborah M. Stephens, Keith L. Duffy, Anneli R. Bowen
Journal of Cutaneous Pathology. 2019-07-01 - 14 citationsCutaneous lesions of angioimmunoblastic T‐cell lymphoma: Clinical, pathological, and immunophenotypic featuresNaoki Oishi, Julio C. Sartori-Valinotti, N. Nora Bennani, David A. Wada, Rong He
Journal of Cutaneous Pathology. 2019-09-01 - 131 citationsSpecificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.David A. Wada, Mark E. Law, Eric D. Hsi, David J. DiCaudo, Linglei Ma
Modern Pathology. 2011-04-01
Press Mentions
Desmoplastic Melanoma Responds to PD-1 Blockade ImmunotherapyMay 26th, 2022
Professional Memberships
- Associate
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
